| |
| Today’s Top Story
Take Action Starting Monday during 2023 Orthopaedic Advocacy Week
AAOS’ 2023 Orthopaedic Advocacy Week begins Monday, July 24, and is your chance to help advance access to and quality of musculoskeletal care. This year, orthopaedic surgeons nationwide will be advocating to protect healthcare professionals against assault and intimidation, remove barriers to timely access to care, implement lasting changes to Medicare physician payment, repeal the moratorium on physician-owned hospitals, and safeguard healthcare when it is needed most. Through simple, minute-long virtual activities, such as posting AAOS graphics on social media or sending prewritten letters to Congress and the Centers for Medicare & Medicaid Services, you can be a part of the charge to advocate for musculoskeletal care.
Prepare to take action next week… |
| |
|
|
|
| |
| In Other News
Simultaneous Bilateral TKA Associated with Increased Risk of 90-day Complications versus Unilateral TKA
A retrospective study in the Journal of Bone and Joint Surgery evaluated the complications associated with and safety of simultaneous bilateral total knee arthroplasty (TKA) compared with unilateral TKA. Ninety-day complications, readmissions, and in-hospital deaths were compared between 21,044 simultaneous bilateral TKA patients and 126,264 matched unilateral TKA patients. Bilateral TKA patients had significantly increased risk of pulmonary embolism, stroke, acute blood loss anemia, and transfusion. Bilateral TKA patients were also more likely to require readmission within 90 days.
Read the abstract… |
| |
|
|
|
| |
| Study: Effects of TXA on Visual Field Clarity and Operation Time in Arthroscopic RCR
Arthroscopy published a systematic review and meta-analysis investigating the effect that tranexamic acid (TXA) has on visual field clarity and operation time during arthroscopic rotator cuff repair (RCR). Of the six randomized controlled clinical trials (RCTs) included, two studies used intraarticular (IA) TXA, and four studies used IV TXA. For the analysis, 227 patients were in the TXA group and 224 patients in the non-TXA group. Two RCTs demonstrated that IV TXA resulted in an improved surgical field of vision when compared with the control group. IA TXA also demonstrated better surgical field of vision and shortened operation times.
Read the study… |
| |
|
|
|
| |
| Machine-vision Image-guided Surgery during Spinal Fusion Linked to Reduced Ionizing Radiation and Intraoperative Blood Loss
Machine-vision image-guided surgery (MvIGS) for screw insertion in posterior spinal fusion (PSF) resulted in significant reductions in intraoperative radiation exposure and fluoroscopy time, according to a study in the European Spine Journal. Clinical and radiographic data were retrospectively reviewed in 6,464 patients undergoing PSF using pedicle screws with 2D fluoroscopy and 64 with the MvIGS. MvIGS reduced fluoroscopy time by 53 percent, radiation exposure by 62 percent, blood loss by 44 percent, and hospital stays by 21 percent. Additionally, scoliosis curve correction improved by 4 percent without increased operation time.
Read the abstract… |
| |
|
|
|
| |
| Study: Efficacy of Local Ketorolac Application in Reducing Postoperative Pain, Hospital Stay, and Postoperative Opioid Use
Current Orthopaedic Practice published a systematic review of the efficacy of ketorolac as an anti-inflammatory and analgesic agent in the perioperative setting. Twenty-one studies assessing more than 3,100 patients who received local injections of ketorolac were identified for analysis via the PubMed database and EMBASE. In general, the reviewed studies consistently showed that ketorolac has a highly favorable safety profile, both systemically and locally. Local application of ketorolac demonstrated decreased postoperative pain, decreased lengths of hospital stay, and decreased postoperative opioid use.
Read the abstract… |
| |
|
|
|
| |
| AAOS Now
July Issue of AAOS Now Is Now Available Online
AAOS members will soon receive the print edition of the July issue of AAOS Now, but the electronic edition is already available on the AAOS Now website. This month’s issue has a topical focus on malpractice and highlights AAOS’ newly launched online toolkit focused on workplace violence, how the recent NFL player judgment could alter the athlete-team physician relationship, how to avoid a medical liability suit, and more.
Read more… |
| |
|
|
|
| |
| Your AAOS
Stay Up to Date in the Rapidly Evolving Area of Orthopaedics
Orthobiologics: Scientific and Clinical Solutions for Orthopaedic Surgeons, edited by internationally renowned experts Scott P. Bruder, MD, PhD, FORS, and Roy K. Aaron, MD, FAAOS, FORS, provides authoritative, comprehensive coverage of this fast-growing field. This one-stop reference is an ideal resource, covering technology and basic science through specific clinical applications. AAOS members enjoy an exclusive 25 percent discount!
Buy your copy today… |
| |
|
|
|
| |
| Introducing OrthoPitch! Coming to the AAOS 2024 Annual Meeting in San Francisco
Get excited for a new technology competition—presented by AAOS and foundational sponsor MCRA—where companies have a chance to present novel, innovative, and potentially disruptive products in the orthopaedic market. OrthoPitch will take place during the AAOS 2024 Annual Meeting. Every application will be thoroughly reviewed by a panel of industry experts and members of the AAOS Devices, Biologics, and Technology Committee. The top three applications will be invited to pitch their concepts live during the AAOS Annual Meeting, with one concept earning bragging rights along with other prizes. Companies can complete the free application until July 27!
Learn more… |
| |
|
